The phenotype of knee joint osteoarthritis in 60 years old and more patients (results of the multicenter ULA study)

  • Authors: Zolotovskaya I.A.1, Davydkin I.L.2, Grigoryeva N.J.3, Tribuntseva L.V.4, Volkorezov I.A.5
  • Affiliations:
    1. FSBEI of Higher Education «Samara state medical university» of the Ministry of Healthcare of Russia
    2. FSBEI of Higher Education «Samara State Medical University» of the Ministry of Healthcare of Russia
    3. FSBEI of Higher Education «Privolzhsky research medical university» of the Ministry of Healthcare of Russia
    4. FSBEI of Higher Education «N.N. Burdenko Voronezh state medical university» of the Ministry of Healthcare of Russia
    5. State healthcare institution «Lipetsk state polyclinic 7»
  • Issue: No 5 (2018)
  • Pages: 83-90
  • Section: Articles
  • URL: https://journals.eco-vector.com/2412-4036/article/view/279476
  • ID: 279476

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The purpose of the study, registered as an observational program ULA and performed between October 2017 and March 2018 on the basis of outpatient clinics in Samara, Voronezh, Lipetsk and Nizhny Novgorod, was the study of the prevalence of concomitant diseases in patients with osteoarthritis (OA) of the knee joint over the age of 60 years. Material and methods. Inclusion / non-inclusion criteria were used in 499 patients (68.0 [65.0, 72.0] years old) in whom were evaluated clinical and demographic data, as well as information on taken medications. Results. According to the analysis of the results, we found that patients with OA over the age of 60 have many comorbidities, including cardiovascular, diabetes (34.3%), chronic kidney disease (36.3%), diabetic polyneuropathy (17.4% %), gastric ulcer (11.2%), chronic gastritis (18.8%), osteoporosis / osteopenia (10.2%), anemia (19.6%), Parkinson's disease (8.2%), glaucoma (10.8%), adenoma of the prostate (8.2%), also they are accepting a wide range of drugs. The highest percentage of drugs is in antihypertensive drugs (calcium channel blockers - 37.0%, ACEI - 40.7%, sartans - 38.3%), diuretics (35.0%), statins (43.0%), β -adrenoceptor blockers (16.2%), α-adrenoblockers (13.0%), sugar-reducing medicaments (25.9%). The level of pain in the knee joint according to the VAS consisted 55.5 ± 12.5 mm, in 31.3% of cases the pain was neuropathic, the average duration of the OA history was 7.0 ± 2.5 years. 92,5% of patients had a history of lower back pain. The conclusion. Obtained data allow to propose for discussion a degenerative-dystrophic phenotype of a patient with OA over 60 years old with a high prevalence of concomitant diseases and wide range of taken medicines in order to formulate a methodology by doctor for making a reasonable decision on the tactics of such patients' curation.

Full Text

Restricted Access

About the authors

Irina A. Zolotovskaya

FSBEI of Higher Education «Samara state medical university» of the Ministry of Healthcare of Russia

Email: zolotovskay@list.ru
PhD, associate professor of the hospital therapy with courses of out-patient therapy and transfusiology Department

Igor L. Davydkin

FSBEI of Higher Education «Samara State Medical University» of the Ministry of Healthcare of Russia

Email: dagi2006@rambler.ru
MD, Professor, pro-rector for scientific and innovative work, head of the Department of hospital therapy with polyclinic therapy and transfusiology, director of the Research Institute of Hematology, Transfusiology and Intensive Care, the chief visiting hematologist of the Ministry of Healthcare of the Samara region

Natalia Ju. Grigoryeva

FSBEI of Higher Education «Privolzhsky research medical university» of the Ministry of Healthcare of Russia

Email: grigoreva28@mail.ru
MD, professor of the Department of faculty and polyclinic therapy

Lyudmila V. Tribuntseva

FSBEI of Higher Education «N.N. Burdenko Voronezh state medical university» of the Ministry of Healthcare of Russia

Email: tribunzewa@yandex.ru
MD, associate professor of the Department of general medical practice (family medicine) and medical examination

Igor A. Volkorezov

State healthcare institution «Lipetsk state polyclinic 7»

MD, rheumatologist

References

  1. Briggs A.M., Cross M.J., Hoy D.G. et al. Musculoskeletal Health Conditions Represent a Global Threat to Healthy Aging: A Report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist. 2016;56(2):243-55. doi: 10.1093/geront/gnw002.
  2. Pereira D., Ramos E., Branco J. Osteoarthritis. Acta Med. Port. 2015;28(1):99-106.
  3. GBD 2016 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study2016. Lancet. 2017;390:1260-344.
  4. Cross M., Smith E., Hoy D. et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann. Rheum. Dis. 2014;73:1323-30. doi: 10.1136/annrheumdis-2013- 204763.
  5. Zhang Y., Jordan J.M. Epidemiology of osteoarthritis. Clin. Geriatr. Med. 2010;26:355-69. doi: https://doi.org/10.1016/j. cger.2010.03.001.
  6. Deshpande B.R., Katz J.N., Solomon D.H. et al. Number of Persons With Symptomatic Knee Osteoarthritis in the US: Impact of Race and Ethnicity, Age, Sex, and Obesity. Arthr. Care Res. (Hoboken). 2016;68:1743-50. doi: 10.1002/acr.22897.
  7. Bruyère O., Cooper C., Pelletier J.P. et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis- From evidence-based medicine to the real-life setting. Semin. Arthr. Rheum. 2016;45:3-11.
  8. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018;56:1-29. doi: 10.14412/1995-4484-2018-1-29
  9. Bannuru R.R., Schmid C.H., Kent D.M. et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann. Intern. Med. 2015;162:46-54. doi: 2088548 pii. 10.73.
  10. Шостак Н.А., Клименко А.А., Демидова Н.А., Кондрашов А.А. Проблема кардиобезопасности противовоспалительных препаратов. Тер. архив. 2016;88 (5) 113-7.
  11. Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis:. Classification of osteoarthritis of the knee: Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthr. Rheum. 1986;29(8):1039-49.
  12. Castaneda S., Roman-Blas J.A., Largo R., Herrero-Beaumont G. Osteoarthritis: a progressive disease with changing phenotypes. Rheum. 2014;53:1-3.
  13. Lauwerys B.R., Hernandez-Lobato D., Gramme P. et al. Heterogeneity of synovial molecular patterns in patients with arthritis. PLoS One. 2015;10:e0122104.
  14. Kriegova E., Manukyan G., Mikulkova Z. et al. Gender-related differences observed among immune cells in synovial fluid in knee osteoarthritis. Osteoarthr. Cartilage. 2018;9. pii: S1063-4584(18)31233-0. doi: 10.1016/j.joca.2018.04.016.
  15. Dell'Isola A., Allan R., Smith S.L. et al. Identification of clinical phenotypes in knee osteoarthritis: a systematic review of the literature. BMC. Musculoskelet Disord. 2016;17:425. https://doi.org/ 10.1186/s12891-016-1286-.
  16. Deveza L.A., Melo L., Yamato T.P. et al. Knee osteoarthritis phenotypes and their relevance for outcomes: a systematic review. Osteoarthr. Cartilage.2017;25(12):1926-41. doi: 10.1016/j.joca.2017.08.009.
  17. Castaneda S., Roman-Blas J.A., Largo R., Herrero-Beaumont G. Osteoarthritis: a progressive disease with changing phenotypes. Rheumat. (Oxford). 2014;53(1):1-3. doi: 10.1093/rheumatology/ket247.
  18. Migliore A., Bizzi E., Herrero-Beaumont J. et al. The discrepancy between recommendations and clinical practice for viscosupplementation in osteoarthritis: mind the gap! Eur. Rev. Med. Pharmacol. Sci. 2015;19(7):1124-9.
  19. Zullig L.L., Bosworth H.B., Jeffreys A.S. et al. The association of comorbid conditions with patientreported outcomes in veterans with hip and knee osteoarthritis. Clin. Rheumatol. 2015; 34:1435-41. https://doi.org/10.1007/s10067-014-2707-y].
  20. Bastick A.N., Wesseling J., Damen J. et al. Defining knee pain trajectories in early symptomatic knee osteoarthritis in primary care: 5-year results from a nation wide prospective cohort study (CHECK). Br. J. Gen. Pract. 2016;66:32-9. doi: https://doi. org/10.3399/bjgp15X688129.
  21. Cardoso J.S., Riley J.L., Glover T. et al. Experimental pain phenotyping in community dwelling individual switch knee osteoarthritis. Pain. 2016;157:2104-14. https://doi.org/10.1097/j.pain. 0000000000000625.
  22. Cruz-Almeida Y., King C.D., Goodin B.R. et al. Psychological profiles and pain characteristics of older adults with knee osteoarthritis. Arthr. Care Res. (Hoboken). 2013;65:1786-94.
  23. Cruz-Almeida Y., Riley J.L., Fillingim R.B. Experimental pain phenotype profiles in a racially and ethnically diverse sample of healthy adults. Pain Med. 2013;14:1708-18.
  24. Bergbom S., Boersma K., Overmeer T., Linton S.J. Relationship among pain catastrophizing, depressed mood, and outcomes across physical therapy treatments. Phys. Ther. 2011;91:754-64.
  25. Van Eijsden-Besseling M.D.F., van Attekum A., de Bie R.A., Staal J.B. Pain catastrophizing and lower physical fitness in a sample of computer screen workers with early non-specific upper limb disorders: a case-control study. Ind. Health. 2010;48:818-23.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies